Brief: Biofrontera Announces Prelim Product Revenues For Q3 2022
05/10/2022 22:10
Oct 5 (Reuters) - Biofrontera Inc BFRI.O :
* BIOFRONTERA INC. ANNOUNCES PRELIMINARY PRODUCT REVENUES
FOR THE
THIRD QUARTER OF 2022
* BIOFRONTERA INC- PRODUCT REVENUES FOR Q3 OF 2022 ARE
ANTICIPATED
TO BE ABOUT $4.3 MILLION
Source text for Eikon: ID:nGNX6qW9Cs
Further company coverage: BFRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales